BioCentury | Sep 1, 2018
Politics, Policy & Law

Back to School 2018: A pathway to Biopharma 3.0

...an atherosclerotic plaque are a major step forward from simple blood tests for cholesterol levels. PlaqueTec Ltd....
...Bioscience Inc., Menlo Park, Calif. Pact Pharma Inc., Hayward, Calif. Pear Therapeutics Inc., Boston, Mass. PlaqueTec Ltd....
BioCentury | Jun 16, 2018
Finance

Rejuvenating aging

...Pfizer. Jenkins is a consulting adviser to Juvenescence. She is CEO of cardiovascular diagnostic company PlaqueTec Ltd....
BioCentury | Apr 13, 2018
Tools & Techniques

Personalizing prevention

...needed to show a benefit, and reduce side effect exposure in patients unlikely to benefit. PlaqueTec’s...
...was a huge breakthrough, and the tip of the iceberg.” Annalisa Jenkins, PlaqueTec According to PlaqueTec...
...in downstream samples are likely to come from the plaques. Source: PlaqueTec Ltd. Building a business PlaqueTec...
BioCentury | Dec 12, 2017
Company News

Management tracks: Achaogen, Minerva

...Dimension Therapeutics Inc., which Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) acquired. She has served as CEO at PlaqueTec Ltd....
BioCentury | Nov 13, 2017
Company News

Management tracks: PlaqueTec, Biohaven

...Liquid biopsy play PlaqueTec Ltd. (Cambridge, U.K.) named Annalisa Jenkins CEO. She was president and CEO of...
BioCentury | Sep 30, 2015
Company News

Management tracks

...will resign effective Sept. 30. Genkyotex CBO Elias Papatheodorou will be acting CEO. Diagnostic play PlaqueTec Ltd....
BioCentury | Sep 1, 2014
Clinical News

Liquid Biopsy System regulatory update

...Biopsy System to collect biological data associated with heart disease from coronary arteries. According to PlaqueTec...
...“specified collaborative studies.” PlaqueTec said a study of LBS has begun at Papworth Hospital Cambridge. PlaqueTec Ltd....
Items per page:
1 - 7 of 7
BioCentury | Sep 1, 2018
Politics, Policy & Law

Back to School 2018: A pathway to Biopharma 3.0

...an atherosclerotic plaque are a major step forward from simple blood tests for cholesterol levels. PlaqueTec Ltd....
...Bioscience Inc., Menlo Park, Calif. Pact Pharma Inc., Hayward, Calif. Pear Therapeutics Inc., Boston, Mass. PlaqueTec Ltd....
BioCentury | Jun 16, 2018
Finance

Rejuvenating aging

...Pfizer. Jenkins is a consulting adviser to Juvenescence. She is CEO of cardiovascular diagnostic company PlaqueTec Ltd....
BioCentury | Apr 13, 2018
Tools & Techniques

Personalizing prevention

...needed to show a benefit, and reduce side effect exposure in patients unlikely to benefit. PlaqueTec’s...
...was a huge breakthrough, and the tip of the iceberg.” Annalisa Jenkins, PlaqueTec According to PlaqueTec...
...in downstream samples are likely to come from the plaques. Source: PlaqueTec Ltd. Building a business PlaqueTec...
BioCentury | Dec 12, 2017
Company News

Management tracks: Achaogen, Minerva

...Dimension Therapeutics Inc., which Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) acquired. She has served as CEO at PlaqueTec Ltd....
BioCentury | Nov 13, 2017
Company News

Management tracks: PlaqueTec, Biohaven

...Liquid biopsy play PlaqueTec Ltd. (Cambridge, U.K.) named Annalisa Jenkins CEO. She was president and CEO of...
BioCentury | Sep 30, 2015
Company News

Management tracks

...will resign effective Sept. 30. Genkyotex CBO Elias Papatheodorou will be acting CEO. Diagnostic play PlaqueTec Ltd....
BioCentury | Sep 1, 2014
Clinical News

Liquid Biopsy System regulatory update

...Biopsy System to collect biological data associated with heart disease from coronary arteries. According to PlaqueTec...
...“specified collaborative studies.” PlaqueTec said a study of LBS has begun at Papworth Hospital Cambridge. PlaqueTec Ltd....
Items per page:
1 - 7 of 7